Complexity makes aging harder to slow down

A European research team, publishing in Mechanisms of Ageing and Development, proposes a theoretical framework to explain this problem. The researchers argue that as an organism becomes more complex, its biological networks become more interconnected. Changing one component then triggers compensation elsewhere in the system, reducing the overall effect.

In the worm C. elegans, a single mutation in the insulin signaling pathway (the IIS pathway) can roughly double lifespan. In fruit flies, comparable effects are smaller and more context-dependent. In mice, rapamycin, one of the most successful longevity drugs, extends lifespan by around ten to twenty-five percent. That is meaningful, but nowhere near what is achievable in worms.

Feedback as a limiting force

The paper’s central argument is that larger networks contain more feedback loops. When mTOR is inhibited, the body partly corrects this through upstream insulin signaling. When one aging pathway is blocked, another partly takes over its role. In mammals, these compensatory mechanisms are stronger than in simple organisms. This also explains why identical interventions sometimes produce very different outcomes in mice versus humans.

Implications for longevity research

The model has practical relevance. It suggests that single longevity interventions in humans are fundamentally limited in their effect. Combination strategies targeting multiple aging pathways simultaneously could theoretically achieve more, but this remains a model prediction, not a proven strategy. The authors emphasize this explicitly as a theoretical framework, not an empirically demonstrated mechanism.

Read the original article